Diagnosis of Pelizaeus-Merzbacher disease: Detection of proteolipid protein gene copy number by real-time PCR

Stefano Regis, Serena Grossi, Susanna Lualdi, Roberta Biancheri, Mirella Filocamo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Duplication of the proteolipid protein gene (PLP1) is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a severe X-linked myelination disorder. We developed an assay for the detection of the PLP1 gene dosage by real-time quantitative PCR using the ABI Prism 7700 Sequence Detection System and the TaqMan chemistry. Copy number of the PLP1 gene was determined by the standard curve method using GAPDH as the reference gene. The assay was tested both on 50 normal controls and on 20 subjects whose PLP1 gene copy number was previously determined by quantitative fluorescent multiplex PCR. The procedure confirmed the expected results both on the male and female normal controls as well as on the 20 subjects previously tested. Ratios corresponding to the presence of one, two or three PLP1 gene copies, distributed in three non-overlapping ranges, were obtained by real-time PCR analysis. Subsequently, 29 DNA samples of putative PMD patients and possible female carriers, with unknown PLP1 gene dosage, were analysed. Five affected males carrying the PLP1 gene duplication and four female heterozygotes carrying three PLP1 gene copies were identified among them. The method is suitable for the identification of affected male patients and female carriers. Specific ranges are widely spaced, ensuring a correct assignment of the PLP1 gene copy number.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalNeurogenetics
Volume6
Issue number2
DOIs
Publication statusPublished - May 2005

Fingerprint

Pelizaeus-Merzbacher Disease
Proteolipids
Gene Dosage
Real-Time Polymerase Chain Reaction
Proteins
Genes
Gene Duplication
Multiplex Polymerase Chain Reaction
Heterozygote
DNA

Keywords

  • Duplication
  • Gene dosage
  • PLP1 gene
  • PMD
  • Real-time PCR

ASJC Scopus subject areas

  • Genetics(clinical)
  • Neuroscience(all)

Cite this

Diagnosis of Pelizaeus-Merzbacher disease : Detection of proteolipid protein gene copy number by real-time PCR. / Regis, Stefano; Grossi, Serena; Lualdi, Susanna; Biancheri, Roberta; Filocamo, Mirella.

In: Neurogenetics, Vol. 6, No. 2, 05.2005, p. 73-78.

Research output: Contribution to journalArticle

@article{3e625c4e541d4424b7c00d6959024857,
title = "Diagnosis of Pelizaeus-Merzbacher disease: Detection of proteolipid protein gene copy number by real-time PCR",
abstract = "Duplication of the proteolipid protein gene (PLP1) is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a severe X-linked myelination disorder. We developed an assay for the detection of the PLP1 gene dosage by real-time quantitative PCR using the ABI Prism 7700 Sequence Detection System and the TaqMan chemistry. Copy number of the PLP1 gene was determined by the standard curve method using GAPDH as the reference gene. The assay was tested both on 50 normal controls and on 20 subjects whose PLP1 gene copy number was previously determined by quantitative fluorescent multiplex PCR. The procedure confirmed the expected results both on the male and female normal controls as well as on the 20 subjects previously tested. Ratios corresponding to the presence of one, two or three PLP1 gene copies, distributed in three non-overlapping ranges, were obtained by real-time PCR analysis. Subsequently, 29 DNA samples of putative PMD patients and possible female carriers, with unknown PLP1 gene dosage, were analysed. Five affected males carrying the PLP1 gene duplication and four female heterozygotes carrying three PLP1 gene copies were identified among them. The method is suitable for the identification of affected male patients and female carriers. Specific ranges are widely spaced, ensuring a correct assignment of the PLP1 gene copy number.",
keywords = "Duplication, Gene dosage, PLP1 gene, PMD, Real-time PCR",
author = "Stefano Regis and Serena Grossi and Susanna Lualdi and Roberta Biancheri and Mirella Filocamo",
year = "2005",
month = "5",
doi = "10.1007/s10048-005-0214-7",
language = "English",
volume = "6",
pages = "73--78",
journal = "Neurogenetics",
issn = "1364-6745",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Diagnosis of Pelizaeus-Merzbacher disease

T2 - Detection of proteolipid protein gene copy number by real-time PCR

AU - Regis, Stefano

AU - Grossi, Serena

AU - Lualdi, Susanna

AU - Biancheri, Roberta

AU - Filocamo, Mirella

PY - 2005/5

Y1 - 2005/5

N2 - Duplication of the proteolipid protein gene (PLP1) is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a severe X-linked myelination disorder. We developed an assay for the detection of the PLP1 gene dosage by real-time quantitative PCR using the ABI Prism 7700 Sequence Detection System and the TaqMan chemistry. Copy number of the PLP1 gene was determined by the standard curve method using GAPDH as the reference gene. The assay was tested both on 50 normal controls and on 20 subjects whose PLP1 gene copy number was previously determined by quantitative fluorescent multiplex PCR. The procedure confirmed the expected results both on the male and female normal controls as well as on the 20 subjects previously tested. Ratios corresponding to the presence of one, two or three PLP1 gene copies, distributed in three non-overlapping ranges, were obtained by real-time PCR analysis. Subsequently, 29 DNA samples of putative PMD patients and possible female carriers, with unknown PLP1 gene dosage, were analysed. Five affected males carrying the PLP1 gene duplication and four female heterozygotes carrying three PLP1 gene copies were identified among them. The method is suitable for the identification of affected male patients and female carriers. Specific ranges are widely spaced, ensuring a correct assignment of the PLP1 gene copy number.

AB - Duplication of the proteolipid protein gene (PLP1) is the most frequent cause of Pelizaeus-Merzbacher disease (PMD), a severe X-linked myelination disorder. We developed an assay for the detection of the PLP1 gene dosage by real-time quantitative PCR using the ABI Prism 7700 Sequence Detection System and the TaqMan chemistry. Copy number of the PLP1 gene was determined by the standard curve method using GAPDH as the reference gene. The assay was tested both on 50 normal controls and on 20 subjects whose PLP1 gene copy number was previously determined by quantitative fluorescent multiplex PCR. The procedure confirmed the expected results both on the male and female normal controls as well as on the 20 subjects previously tested. Ratios corresponding to the presence of one, two or three PLP1 gene copies, distributed in three non-overlapping ranges, were obtained by real-time PCR analysis. Subsequently, 29 DNA samples of putative PMD patients and possible female carriers, with unknown PLP1 gene dosage, were analysed. Five affected males carrying the PLP1 gene duplication and four female heterozygotes carrying three PLP1 gene copies were identified among them. The method is suitable for the identification of affected male patients and female carriers. Specific ranges are widely spaced, ensuring a correct assignment of the PLP1 gene copy number.

KW - Duplication

KW - Gene dosage

KW - PLP1 gene

KW - PMD

KW - Real-time PCR

UR - http://www.scopus.com/inward/record.url?scp=20044380378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044380378&partnerID=8YFLogxK

U2 - 10.1007/s10048-005-0214-7

DO - 10.1007/s10048-005-0214-7

M3 - Article

C2 - 15827763

AN - SCOPUS:20044380378

VL - 6

SP - 73

EP - 78

JO - Neurogenetics

JF - Neurogenetics

SN - 1364-6745

IS - 2

ER -